Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Cabibbo, G."'
Autor:
Guarino, M., Cucchetti, A., Pontillo, G., Farinati, F., Benevento, F., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Rodolfo, S., Cabibbo, G., Marra, F., Mega, A., Gasbarrini, A., Svegliati-Baroni, G., Foschi, F. G., Missale, G., Masotto, A., Nardone, G., Raimondo, G., Azzaroli, F., Vidili, G., Oliveri, F., Trevisani, F., Giannini, E. G., Morisco, F., Biselli, M., Caraceni, P., Garuti, F., Gramenzi, A., Neri, A., Rampoldi, D., Santi, V., Forgione, A., Granito, A., Muratori, L., Piscaglia, F., Sansone, V., Tovoli, F., Dajti, E., Marasco, G., Ravaioli, F., Cappelli, A., Golfieri, R., Mosconi, C., Renzulli, M., Cela, E. M., Facciorusso, A., Pelizzaro, F., Imondi, A., Sartori, A., Penzo, B., Cacciato, V., Casagrande, E., Moscatelli, A., Pellegatta, G., Pieri, G., de Matthaeis, N., Allegrini, G., Lauria, V., Ghittoni, G., Pelecca, G., Chegai, F., Coratella, F., Ortenzi, M., Olivari, A., Inno, A., Marchetti, F., Busacca, A., Camma, C., Di Martino, V., Rizzo, G. E. M., Franze, M. S., Saitta, C., Sauchella, A., Bevilacqua, V., Borghi, A., Gardini, A. C., Conti, F., Berardinelli, D., Ercolani, G., Napoli, L., Campani, C., Di Bonaventura, C., Gitto, S., Coccoli, P., Malerba, A., Capasso, M., Fiorentino, A., Pignata, L., Cossiga, V., Romagnoli, V.
Publikováno v:
European Journal of Clinical Investigation. 51
Background and aims: In patients with hepatocellular carcinoma (HCC), macrovascular invasion (MaVI) limits treatment options and decreases survival. Detailed data on the relationship between MaVI extension and patients' characteristics, and its impac
Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?
Publikováno v:
Scopus-Elsevier
Direct-acting antivirals (DAAs) revolutionised the treatment of chronic HCV-related disease achieving high rates of sustained virological response (SVR), also in more advanced patients, with a good safety profile and a proven positive effect on the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::62b212e9375d076ccb57acf8fc075c0f
http://hdl.handle.net/10447/404051
http://hdl.handle.net/10447/404051
Autor:
Piscaglia, Fabio, Svegliati Baroni, Gianluca, Barchetti, Andrea, Pecorelli, Anna, Marinelli, Sara, Tiribelli, Claudio, Bellentani, Stefano, Bernardi M, Biselli M, Bernardi M, Biselli M, Caraceni P, Domenicali M, Garuti F, Gramenzi A, Lenzi B, Magalotti D, Cescon M, Ravaioli M, Del Poggio P, Olmi S, Rapaccini GL, Balsamo C, Di Nolfo MA, Vavassori E, Alberti A, Benvegnù L, Gatta A, Giacomin A, Vanin V, Pozzan C, Maddalo G, Giampalma E, Cappelli A, Golfieri R, Mosconi C, Renzulli M, Roselli P, Dell'Isola S, Ialungo AM, Risso D, Marenco S, Sammito G, Bruzzone L, Bosco G, Grieco A, Pompili M, Rinninella E, Siciliano M, Chiaramonte M, Guarino M, Cammà C, Maida M, Costantino A, Barcellona MR, Schiadà L, Gemini S, Lanzi A, Stefanini GF, Dall'Aglio AC, Cappa FM, Suzzi A, Mussetto A, Treossi O, Missale G, Porro E, Mismas V, Vivaldi C, Bolondi L, Zoli M, Granito A, Malagotti D, Tovoli F, Trevisani F, Venerandi L, Brandi G, Cucchetti A, Bugianesi E, Vanni E, Mezzabotta L, Cabibbo G, Petta S, Fracanzani A, Fargion S, Marra F, Fani B, Biasini E, Sacco R, CAPORASO, NICOLA, Colombo M, D'Ambrosio R, Crocè LS, Patti R, Giannini EG, Loria P, Lonardo A, Baldelli E, Miele L, Farinati F, Borzio M, Dionigi E, Soardo G, Caturelli E, Ciccarese F, Virdone R, Affronti A, Foschi FG, Borzio F., MORISCO, FILOMENA
none 31 no Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome and may evolve into hepatocellular carcinoma (HCC). Only scanty clinical information is available on HCC in NAFLD. The aim of this multicen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d81e603ea197293ff25650d5d3692b35
http://hdl.handle.net/11577/3212140
http://hdl.handle.net/11577/3212140
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease
Autor:
Bortolotti F., Cammà C., Cabibbo G., Zancan L., Indolfi G., Giacchino R., Marcellini M., Marazzi MG, Barbera C., Maggiore G., Vajiro P., Bartolacci S., Balli F., Maccabruni A., Guido M., the Italian Observatory for HCV Infection, Hepatitis C. in Children, VERUCCHI, GABRIELLA
Publikováno v:
Gastroenterology. 134(7)
Background & Aims: The natural course of chronic hepatitis C (CHC) in children is not well understood. The aim of this study was to assess the long-term course of CHC in a large sample of otherwise healthy children. Methods: From 1990 to 2005, 504 co
Autor:
Maria Reig, Giuseppe Cabibbo
The potential impact of direct-acting antivirals (DAAs) in patients with Barcelona Clinic Liver Cancer (BCLC)-B/C stage hepatocellular carcinoma (HCC) is understudied. Patients with HCC have been systematically excluded from randomised controlled tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6aa19c68e75f590c9f5a31546943360
https://hdl.handle.net/10447/544082
https://hdl.handle.net/10447/544082
Autor:
Salvatore Petta, Antonio Craxì, Giuseppe Malizia, Gaetano Bertino, Giuseppe Cabibbo, Salvatore Battaglia, G. Scifo, Irene Cacciola, Maurizio Russello, Giovanni Squadrito, F. Cartabellotta, Giovanni Raimondo, F. Benanti, Tullio Prestileo, A. Montineri, Vincenza Calvaruso, Calogero Cammà, Salvatore Madonia, Maria Antonietta Di Rosolini, A. Digiacomo, Marco Enea, Marco Distefano, Anna Licata, Vito Di Marco
Publikováno v:
Journal of Viral Hepatitis
Real-world evidence on the course of Hepatitis C Virus (HCV) chronic liver disease after Sustained Virologic Response (SVR) obtained with direct-acting antiviral drugs (DAAs) are still limited, and the effects on mortality remain unclear. We evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c22f346363d4daf5ee851ffd77e465
http://hdl.handle.net/10447/514448
http://hdl.handle.net/10447/514448
Autor:
Concetta Pitrone, Vito Di Marco, Gabriele Rancatore, Ciro Celsa, Paolo Giuffrida, Caterina Stornello, Calogero Cammà, Giuseppe Cabibbo, Carmelo Marco Giacchetto, Mauro Grova
Publikováno v:
Annals of Hepatology, Vol 27, Iss, Pp 100568-(2022)
Direct-acting antivirals (DAAs) revolutionized the treatment of chronic HCV-related disease achieving high rates of sustained virological response (SVR), even in advanced cirrhosis, with modest contraindications and a low rate of adverse events. Howe
Autor:
Giovanni Galati, Moises Muley, Mauro Viganò, Massimo Iavarone, Alessandro Vitale, Chiara Dell’Unto, Quirino Lai, Giuseppe Cabibbo, Rodolfo Sacco, Erica Villa, Franco Trevisani
Introduction: Concerns were raised about a high occurrence of hepatocellular carcinoma (HCC) after successful treatment of chronic hepatitis C (CHC) by direct-acting antivirals (DAAs). Areas covered: The authors summarize the clinical studies reporti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c2bc6d8c186bd6561ad06bfe6c89f7
http://hdl.handle.net/11585/729057
http://hdl.handle.net/11585/729057
Autor:
V. Boccaccio, Alessio Aghemo, Giuseppe Cabibbo, Mauro Viganò, Luigi Roffi, Savino Bruno, Massimo Iavarone, Antonio Craxì, Vincenza Calvaruso, Vito Di Marco, Massimo Colombo, Patrick Maisonneuve, Andrea Crosignani
Publikováno v:
Europe PubMed Central
Background & Aims: Life expectancy of patients with compensated hepatitis C virus (HCV) cirrhosis achieving sustained virologic response (SVR) is limited by liver events as compared to the general population. Thus, survival benefit of SVR remains to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7f1d57a8db38c6c0367216617d1769
http://hdl.handle.net/10447/282341
http://hdl.handle.net/10447/282341